You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 164 No. 2, January 26, 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Chronic Obstructive Pulmonary Disease
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

In-Hospital Mortality and Long-term Use of Inhaled Corticosteroids—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In reply

Dr Punnam asks if systemic corticosteroid or ICS use prior to admission for acute exacerbations of COPD influenced inpatient mortality. The objectives of our study1 were to obtain a generalizable estimate of in-hospital COPD mortality and to identify high-risk groups using readily available administrative data. Determining the impact of specific therapies on hospital outcomes was not one of our goals and unfortunately cannot be addressed with the data source used in our study (the Nationwide Inpatient Sample [NIS] does not contain information about medications on hospital admission).

A number of clinical trials have reported benefits of systemic corticosteroids for the treatment of COPD exacerbations (eg, improved pulmonary function and reduced rates of reexacerbations). To our knowledge, there are no clinical trial data to indicate that systemic corticosteroid use reduces mortality from COPD exacerbations. Evidence from clinical trials suggests that long-term ICS use does not delay the progressive loss . . . [Full Text of this Article]

Susheel P. Patil, MD; Jerry A. Krishnan, MD; Noah Lechtzin, MD, MHS; Gregory B. Diette, MD, MHS
Baltimore, Md



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

In-Hospital Mortality and Long-term Use of Inhaled Corticosteroids
Sujeeth R. Punnam
Arch Intern Med. 2004;164(2):222.
EXTRACT | FULL TEXT  

In-Hospital Mortality Following Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Susheel P. Patil, Jerry A. Krishnan, Noah Lechtzin, and Gregory B. Diette
Arch Intern Med. 2003;163(10):1180-1186.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.